Published by mark itwired
Posted on September 30, 2021
3 min readLast updated: February 1, 2026
The OPEP devices market is set to grow at a 5% CAGR from 2019 to 2029, driven by increased adoption for respiratory diseases like COPD.
A new market research report by Future Market Insights (FMI) on the oscillating positive expiratory pressure (OPEP) devices market includes global industry analysis 2014–2018 and opportunity assessment 2019–20289. According to report findings, the global oscillating positive expiratory pressure devices market was valued ~US$ 100.0 Mn in 2018, and is expected to increase at a CAGR of ~5% during the forecast period of 2019 and 2029.
The study opines that the global OPEP devices market is projected to witness significant growth over the forecast period due to multiple driving factors such as increasing regional availability of the oscillating positive expiratory pressure devices. The promising growth prospects are attributed to the innovative approach followed by manufacturers in designing devices, and the increasing adoption of OPEP devices among patients with respiratory diseases.
Download the sample copy of Report with table of contents and Figures @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3397
Regions such as North America and Europe are expected to hold a prominent market share in terms of value. However, the East Asia market is expected to project lucrative growth in the global oscillating positive expiratory pressure devices market in the forecast period of 2019-2029. This growth is majorly propelled by increasing regional manufacturers resulting in increased product availability at affordable costs.
Furthermore, prevalence of chronic obstructive pulmonary diseases (COPD) is on the rise due to increasing smoking population in China and aging population in Japan with respiratory disorders. Although, low awareness about oscillating positive expiratory pressure devices among healthcare professionals and patients is hampering the potential growth of the oscillating positive expiratory pressure devices market.
Mouthpiece OPEP Devices – Preferred Choice for Airway Clearance
Based on the analysis of OPEP devices market by product, mouthpiece oscillating positive expiratory pressure devices are expected to hold a prominent value share in the global market. This, according to FMI’s analysis, has majorly resulted from the ease of use of these devices as well as comparatively wider availability in the market.
On the other side, based on indication, the COPD is likely to consume a majority share of the oscillating positive expiratory pressure devices market value. This is majorly due to the higher prevalence of the disease and adoption of oscillating positive expiratory pressure devices for disease management. Although, cystic fibrosis is rare disease and has limited patient pool yet adoption of oscillating positive expiratory pressure devices remains highest in cystic fibrosis patients.
Request a report sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3397
OPEP Devices Market: Vendor Insights
The report highlights some of the prominent market players, who have established themselves as leaders in the global oscillating positive expiratory pressure devices market. Some of the prominent key players in the global OPEP devices market are Smiths Medical Inc., Allergan plc, PARI GmbH, Monaghan Medical Corporation, Trudell Medical International, Actegy Health Ltd., WyMedical Pty Ltd, R. Cegla GmbH & Co. KG, etc.
The global oscillating positive expiratory pressure devices market is significantly consolidated, with top two players holding prominent shares in the market revenues. These players are offering oscillating positive expiratory pressure devices under their popular brands such as Portex®, Flutter®, and Aerobika®, among others.
The post Oscillating Positive Expiratory Pressure Devices Market is anticipated to grow at a CAGR of ~5% during 2019 to 2029 first appeared on Market Research Blog.
The article discusses the growth of the OPEP devices market, expected to expand at a 5% CAGR from 2019 to 2029.
Market growth is driven by innovation in device design and increased adoption for respiratory disease management.
North America and Europe are key players, with East Asia showing significant growth potential.
Explore more articles in the Research Reports category
